AzTrials
AzTrials

Polycystic Ovary SyndromeNCT03068221

Clinical Sciences Research Proposal- The Effect of Physical Exercise on PCOS Overweight Female Adolescents

A study testing anaerobic exercise in people with Polycystic Ovary Syndrome and Overweight, run by Meir Medical Center at 1 site in Israel.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The Poly Cystic Ovary Syndrome (PCOS), is one of the most common reasons for subfertility, oligomenorrhea and amenorrhea. With the occurrence of 6-20% of the general adult women population. One of the main criteria of this syndrome is a hyper androgenic state. More than 50% of women who have PCOS are overweight. Read more about this study

Who is it for?
Ages 10 to 25 years, women onlyHealthy volunteers can take part
Conditions the study is for
Polycystic Ovary Syndrome, Overweight
What is being tested?
anaerobic exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteIsrael
Study dates
15 Mar 2017to 30 Oct 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 25 years
  • Women only
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • post menarche female
  • PCOS diagnosis
  • overweight- BMI above 85 percent.

Who cannot join

  • inability to complete the physical activity due to health issues
  • Thyroid dysfunction (hyper-, hypo-)
  • hyperprolactinemia
  • congenital adrenal hyperplasia

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Meir Medical Center , Tel Aviv University

    Kfar Saba

Other trials in Israel

About this study

Official title: Clinical Sciences Research Proposal- The Effect of Physical Exercise on Poly Cystic Ovary Syndrome Overweight Female Adolescents

The Poly Cystic Ovary Syndrome (PCOS), is one of the most common reasons for subfertility, oligomenorrhea and amenorrhea. With the occurrence of 6-20% of the general adult women population. One of the main criteria of this syndrome is a hyper androgenic state.

More than 50% of women who have PCOS are overweight. In the teenage population, PCOS is common in 5-10% of teenage girls. A recent research has shown that elite athlete teenage girls have higher serum androgen levels, especially in anaerobic types of sport.

The purpose of this experiment is to examine the reaction of teenage PCOS overweight girls towards anaerobic exercise. To determine if their hyperandrogenic state is more adapted to excel in anaerobic exercise compared to teenage overweight girls without PCOS.

Read the detailed description

30 teenage and young adult females, aged 10-25 years old. The minimum hormonal age for inclusion is menarche. Overweight- with a Body Mass Index (BMI) percentage above 85%, divided into 2 groups: 15 girls with diagnosed PCOS, and 15 girls without diagnosed PCOS, without any other medical comorbidities. Followed at the pediatric endocrinology unit.

The 2 groups would participate in 2 anaerobic tests to evaluate their performances. The data received will be used to evaluate their anaerobic attributes, and for comparison between the 2 groups to determine any differences.

The participants will be asked to refrain from any form of physical exercise during the previous day.

After explanation to the patient and his parent and obtaining an informed consent, the participants will start the tests.

The first test is the Repeated Sprint Test: The participant will run a distance of 40 meters, for 6 repetitions. The optimal running time will be calculated, total running time and the Performance Decrement of the run will be calculated.

After that, there will be a 1-1.5 hours resting phase. The second test is the "Wingate Test"- the participants will be instructed to pedal at a maximal pace for 30 seconds on an ergometric bicycle against a resistance adjusted according to their BMI. The Peak Anaerobic Power, the Mean Anaerobic Power and the Fatigue Index will be calculated.

Being tested
anaerobic exercise
Medical subject headings
Polycystic Ovary Syndrome, Overweight

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • anaerobic exerciseOther

    assessing anaerobic exercise status

Study groups in NCT03068221
Study groupRoleWhat they receive
Poly Cystic Ovary SyndromeActive comparatoranaerobic exercise in overweight patients with PCOS
Receives: Other: anaerobic exercise
non Poly Cystic Ovary SyndromeActive comparatoranaerobic exercise in overweight patients without PCOS
Receives: Other: anaerobic exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Peak anaerobic power

    The highest produced power (Watt/Kg) during cycling at maximal speed against a weight based calculated resistance for 30 seconds

    Measured: 30 seconds

  2. Mean anaerobic power

    The mean produced power (Watt/Kg) during cycling at maximal speed against a weight based calculated resistance for 30 seconds

    Measured: 30 seconds

Secondary outcomes (1)
  1. Total running time (Seconds) for a repeated sprint test.

    6 repetitions of 40 meter sprint, as fastest as the patient can run

    Measured: between 40-120 seconds

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Mar 2017
  2. Study start15 Mar 2017
  3. Primary completion30 Sep 2019
  4. Study completion30 Oct 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03068221
Sponsor's protocol ID
0342-16CTIL
Status last verified
Dec 2019
First submitted
12 Feb 2017
Last updated
11 Dec 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing anaerobic exercise in people with Polycystic Ovary Syndrome and Overweight, run by Meir Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Dec 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Peak anaerobic power (time frame: 30 seconds). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in